{"name":"Marinomed Biotech AG","slug":"marinomed-biotech-ag","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Respiratory","slug":"respiratory","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Rhinocort","genericName":"Rhinocort","slug":"rhinocort","indication":"Allergic rhinitis","status":"marketed"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Budesolv","genericName":"Budesolv","slug":"budesolv","indication":"Other","status":"phase_3"}]}],"pipeline":[{"name":"Rhinocort","genericName":"Rhinocort","slug":"rhinocort","phase":"marketed","mechanism":"Matrix metalloproteinase-9, Probable G-protein coupled receptor 97, Glucocorticoid receptor","indications":["Allergic rhinitis","Asthma","Asthma management","Nasal polyp","Rhinitis"],"catalyst":""},{"name":"Budesolv","genericName":"Budesolv","slug":"budesolv","phase":"phase_3","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxQa1EzVDFkU3FmY1VUajZ6ZXhnVnBNTjdURXNES3dsRVpYNDlRU1dweUg1Y3lIZ2ZueDhsTFo2anE2dHIyeHhFX1NDUU5pdUtBV3VFdl9vOUNCcU9NejhKZUJnY21jdy1ISFNrYWxYSlVWZl9kX1l1c2hVdUZfVlhaSUtWTDM4MHBzbTFiU3lBdFRDQkkz?oc=5","date":"2026-04-06","type":"trial","source":"openPR.com","summary":"Allergic Conjunctivitis Clinical Trials Landscape 2026: - openPR.com","headline":"Allergic Conjunctivitis Clinical Trials Landscape 2026:","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxPbXl2Z3lRazUwajByd3UyMHhXODZiWmVVdFVuaTE5TlFuWFlZMnR3MXhpNHZ2T2lvNlBRWGd6WVpDRHpQZkZBNUlTa2lpYUJXRjZMTnhOcWdCczB1UlhENEc4ZmhQejYzNGx5Nk5XdUxScmxHUFNWSWhPbUF2UjJrd0JuNTZpVEdickNiMUFUMmtmamtXbHJNeDFsZWRRUXdHNlRMcEdRem9Xa2drcUtoWXF2NjlNRERFdDBYZzJxVnk?oc=5","date":"2026-03-19","type":"pipeline","source":"TradingView","summary":"Marinomed Biotech Announces Capital increase with subscription rights - TradingView","headline":"Marinomed Biotech Announces Capital increase with subscription rights","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6AFBVV95cUxOR0s2NDlXV3NmNDNYbHRlLU5INnI4Zy1YU0FEQzdZSVhHM0RFXzcyOUkybGhueHBlMjdmMFpBcjE0YmpWSlJmRTlRNjg5YTBtSkRaZUFxRUlmUlpiNmk2MlV6T2o0Ql9FRE1iSVBacnU3YjBfZ09KS1VCclk2b1JpUDBZcW4zTnlobC1UZUxJN2l1aFAwRHp4aXNvWUU4Ry1TWGI4UDh2NWxrRlJIaTNQT3ZienVlclMtelpPV0hQTzRUZ0Q5RkM5b1lJcVpoUGhaVUdrdUtUZTBJQ21nUUhISTdfVFRTcl85?oc=5","date":"2026-03-19","type":"pipeline","source":"marketscreener.com","summary":"Marinomed Biotech AG has decided to conduct a cash capital increase to cover short-term capital requirements of approximately EUR 2 million - marketscreener.com","headline":"Marinomed Biotech AG has decided to conduct a cash capital increase to cover short-term capital requirements of approxim","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwJBVV95cUxOOFVzZGhrVzRxTDVGcDJsZlVhWkRYRlc5czJ3LWd4bV9jdVpkaGxaRmdrU0FYX0tEQm1ROFNIQ3RDLUlqd1I0N0RhSGhLSk1sQjFRTDMyR2Q1bmVTM2lEVWthSnF3OWU2MkZiYlF3cXFUd0ZDSXA4dHlxOC1VaEp4Y2lBak5acXhjUWp6R1RYbkl5b0NOWXNFRGRsZC1nTGVMYUFfXzhNbW5WVEJwY2s0bmNIVVE0cmVWUmQzNTN2VmxfbnkzS1dHaGdJLXRlODBwcWRMYWYzd0R1OGdLRkRWU0ZjNEZpRG1ONF96X2wyb0t2dGFHMXRxUEFFdmc4cGU1eGZXcDNlUk9KbE9raTZvSUVUdUhDM2FZR1VNUWNGWW1HMXNGTmdr?oc=5","date":"2025-10-13","type":"pipeline","source":"PR Newswire","summary":"Allergic Rhino-Conjunctivitis Market Poised for Significant Growth in the Coming 10 Years Amid Increasing Therapeutic Advancements | DelveInsight - PR Newswire","headline":"Allergic Rhino-Conjunctivitis Market Poised for Significant Growth in the Coming 10 Years Amid Increasing Therapeutic Ad","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxPZWZidW9YNUhxZWkzN1dUT1E5THB5aXViRGFnNzNONTFlTUtfRFdSd2t4bkhKcERiaHhYcHp4eFRCMWRCNnFXbi12cjZYWU1sZDlId0V3Y1FYSzNQaXdveHNBcDRQX0c0aWZpVUlUUmxRVWJYcjJ5RE5Pblp4ZHFxeFJFM1V4Q3dJcXpINjZQbw?oc=5","date":"2024-08-15","type":"pipeline","source":"Wiener Börse","summary":"Marinomed Biotech AG stock price at wienerborse.at/en - Wiener Börse","headline":"Marinomed Biotech AG stock price at wienerborse.at/en - Wiener Börse","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAJBVV95cUxOYXBSbUVBb2J3ZHRCMnFmTnFfSzVIMVR6QTJKTUpkRFpSb0dOd3F4bXpGODhHeFFnRW9TTE5FMEhzVExDbS04ZjZHa2Q0eEpMX3MtNmZVenA3bEJfX25DOFNFOGFFY0R1M0dEVGFkOTdIMHpDaTBaTWJ4TlhBTW5pSVlBY2h1ODFraDBpR0xSR3FtTXRScXBRVTFYSjR3bnYtdWRoX1cxTzcxTHE3Ul90cl9uUWNmTUdiNjVxbUJ3VHdSOGlzemJONjdOVWp6V1BfV2NYM0ExVnFxSHdqSjlXNTRhU204al9iOWZXMFFjWkNydk1oTzlLS3FyN0c5YXVK?oc=5","date":"2024-07-03","type":"regulatory","source":"The AI Journal","summary":"Marine Biotechnology Market size is set to grow by USD 4.71 billion from 2024-2028, Increase in demand for biofuel to boost the market growth, Technavio - The AI Journal","headline":"Marine Biotechnology Market size is set to grow by USD 4.71 billion from 2024-2028, Increase in demand for biofuel to bo","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxPS1VObkE3UVc2UHhsTXp1MnB0VEg2akhLaGtLMllKdTRHUGhRY2FMTWl6MDZYaTVLSDdOQmZBT1ktZnFrODdWR0R2NXFTaU1yRjB3LXVHYi12Ui1NZC1TSjNhSnQ2a2h0a0RBbTNUUkt0UExUd0FlblZYV2wwVHZTT0laX0E5US1pSVQ4Vmh0WElGUWJ6V0NETkFMYTRxUklaYUpWSHRZOTdRdWFWdGROcnJ1VlJzZkVuS2ZuQ2p0LU9CbHJyS09IZWl3?oc=5","date":"2020-10-09","type":"pipeline","source":"BioSpectrum Asia","summary":"Marinomed Biotech develops novel drug for the treatment of autoimmune gastritis - BioSpectrum Asia","headline":"Marinomed Biotech develops novel drug for the treatment of autoimmune gastritis","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"marketed":1,"phase_3":1},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}